Clinical Trial Update: Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas.

View source ↗

Summary

Completed clinical trial update reporting molecular characterization and outcomes in aggressive B-cell lymphomas, including Diffuse Large B-Cell Lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Andrés José Maria Ferreri | Conditions: Diffuse Large B Cell Lymphoma (DLBCL) | Status: COMPLETED